Author: Matt Mauney

A patient diagnosed with pleural and peritoneal mesothelioma today can survive well beyond expectations, provided personalized treatment can be found at a specialty center. Research from the Columbia University Medical Center in New York City has shown that despite the poor prognosis typically accompanies this rare diagnosis, patients still can thrive. “This is an understudied,…

The post Pleural and Peritoneal Mesothelioma Combination Can Be Managed appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Officials with USA Water Polo are confident that organizers of the 2020 Tokyo Summer Olympics will fix an ongoing asbestos issue at the water polo venue for this year’s games. Japanese newspaper The Asahi Shimbun originally reported that officials had discovered asbestos-containing insulation in at least two locations of the Tatsumi International Swimming Center in…

The post US Officials Respond to Asbestos Issue at Tokyo 2020 Water Polo Venue appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Dr. Michele Carbone at the University of Hawaii Cancer Center has good reason to start 2020 optimistic about advancing the treatment of malignant pleural mesothelioma. The National Institutes of Health awarded his research team a five-year, $2.6 million grant last month to continue its work linking the BAP1 gene mutation to the development of mesothelioma…

The post Mesothelioma Genetic Research Team Receives $2.6M Grant from NIH appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

An international team of pathologists has identified a new protein often found on pleural mesothelioma tumor cells. The discovery could lead to a more accurate prognosis for patients and future treatment advances. Researchers found for the first time that mesothelioma patients expressing higher levels of the CD70 protein typically experience a much shorter survival, regardless…

The post Study: Mesothelioma Patients with CD70 Protein Have Worse Prognosis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Officials in Asbestos, Quebec, have been struggling for years to develop a new identity for the small Canadian mining town. Changing its name might do the trick. Mayor Hugues Grimard announced recently that his town in southeastern Quebec is looking for a name change in 2020, believing it could spark a much-needed economic recovery. The…

The post Canadian Town of Asbestos Changing Its Name for Economics appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Less is usually better than more when it comes to aggressive surgery for pleural mesothelioma, according to the latest and most-extensive comparative study. Throughout the last 25 years, surgical patients typically fared better with the lung-sparing pleurectomy and decortication (P/D) than with the more radical extrapleural pneumonectomy (EPP). “We found that the P/D approach should…

The post Comparative Study Reveals Best Mesothelioma Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Thoracic surgeon Dr. Marcelo DaSilva came to Orlando, Florida, with a lofty goal. He wants to make Central Florida a destination for patients diagnosed with malignant pleural mesothelioma. DaSilva also has the tools to make that goal a reality, building a mesothelioma specialty program at AdventHealth Orlando. “We want to make this a nationally —…

The post DaSilva Building Mesothelioma Specialty Program in Orlando appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Memorial Sloan Kettering Cancer Center in New York City has opened its latest clinical trial for patients with pleural mesothelioma, studying the effectiveness of an immunotherapy and chemotherapy combination prior to aggressive surgery. The novel feasibility study will determine if the use of Opdivo (nivolumab) with Alimta (pemetrexed) and either cisplatin or carboplatin — without…

The post Latest Mesothelioma Clinical Trial Opens at Memorial Sloan Kettering appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The goal of the Pacific Mesothelioma Center is to be the most innovative nonprofit research and cancer treatment organization in the world. Its latest fundraising event is a perfect example. As part of the Pacific Heart, Lung & Blood Institute, the Pacific Mesothelioma Center will play a major role in the unMASKing the Cure for…

The post Celebrities Paint Masks for Mesothelioma Fundraising Event appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A new report reveals Johnson & Johnson rushed the test results of its iconic baby powder to show it was free of asbestos contamination. The Wall Street Journal reported Sunday that two independent laboratories found no evidence of asbestos in the same recalled lot of baby powder used in the U.S Food and Drug Administration…

The post Johnson & Johnson Rushed Tests of Asbestos in Baby Powder appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001. The long-running threat has come to fruition. Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade…

The post Mesothelioma Death from 9/11 Signals Start of Things to Come appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The asbestos cleanup of Libby, Montana, is coming to a celebrated close. Unfortunately, the impact of one of America’s worst man-made environmental disasters will continue. The Environmental Protection Agency will soon bring closure to the 19-year, $600 million effort to right the wrongs created by the shuttered W.R. Grace and Co. vermiculite mine, which was…

The post Bittersweet Ending to Asbestos Cleanup in Libby, Montana appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The Miami Cancer Institute on Thursday will begin using the innovative Tumor Treating Fields device for patients with malignant pleural mesothelioma. It is the first new treatment approved for mesothelioma by the U.S. Food and Drug Administration in more than 15 years. “This is actually pretty exciting for us,” Dr. Rupesh Kotecha, the radiation oncologist…

The post Miami Cancer Institute Begins Using Novel Treatment for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Dr. Giovanni Ceresoli doesn’t think Tumor Treating Fields will work for every patient with mesothelioma cancer, but he knows it will work for some. They are in his clinic. As the principal investigator of the multicenter clinical trial that led to approval by the U.S. Food and Drug Administration in May, Ceresoli has played a…

The post Tumor Treating Fields Showing Early Success for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Major retailers have stopped selling the 22-ounce bottles of Johnson & Johnson baby powder after last week’s announcement that the U.S. Food and Drug Administration found traces of asbestos in one of the containers. Exposure to asbestos, a naturally occurring mineral and known carcinogen, is the primary cause of malignant mesothelioma, a rare and aggressive…

The post Major Retailers Pull J&J Baby Powder After FDA Finds Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.